Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene

International Journal of Cancer

Volumn 69, Issue 4, 1996, Pages 312-316

  Fink, Monika ^a   Weinhäusel, Andreas ^a   Niederle, Bruno ^b   Haas, Oskar A ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b Surgical University Clinic   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; AUSTRIA; BASE SEQUENCE; CARCINOMA, MEDULLARY; CODON; DNA MUTATIONAL ANALYSIS; DROSOPHILA PROTEINS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0029848352     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7     Document Type: Article

References (23)

1. BLAUGRUND, J.E., JOHNS, M.M., JR., EBY, Y.J., BALL, D.W., BAYLIN, S.B., HRUBAN, R.H. and SIDRANSKY, D., RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum. mol. Genet., 3, 1895-1897 (1994).
2. BOLINO, A. and 12 OTHERS, RET mutations in exons 13 and 14 of FMTC patients. Oncogene, 10, 2415-2419 (1995).
3. CARLSON, K.M., BRACAMONTES, J., JACKSON, C.E., CLARK, R., LACROIX, A., WELLS, S.A., JR. and GOODFELLOW, P.J., Parent-of-origin effects in multiple endocrine neoplasia type 2B. Amer. J. hum. Genet., 55, 1076-1082 (1994a).
4. CARLSON, K.M., DOU, S., CHI, D., SCAVARDA, N., TOSHIMA, K., JACKSON, C.E., WELLS, S.A., JR., GOODFELLOW, P.J. and DONIS-KELLER, H., Single mis-sense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. nat. Acad. Sci. (Wash.), 91, 1579-1583 (1994b).
5. CECCHERINI, I. and 14 OTHERS, DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene, 9, 3025-3029 (1994).
6. DONIS-KELLER, H., Dou, S., CHI, D., CARLSON, K.M., TOSHIMA, K., LAIRMORE, T.C., HOWE, J.R., MOLEY, J.F., GOODFELLOW, P. and WELLS, S.A., JR., Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. mot. Genet., 2, 851-856 (1993).
7. ENG, C. and 12 OTHERS, Mutations of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chrom. Cancer, 12, 209-212 (1995a).
8. ENG, C., SMITH, D.P., MULLIGAN, L.M., HEALEY, C.S., ZVELEBIL, M.J., STONEHOUSE, T.J., PONDER, M.A., JACKSON, C.E., WATERFIELD, M.D. and PONDER, B.A.J., A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene, 10, 509-513 (1995b).
9. ENG, C., SMITH, D.P., MULLIGAN, L.M., NAGAI, M.A., HEALEY, C.S., PONDER, M.A., GARDNER, E., SCHEUMANN, G.F.W., JACKSON, C.E., TUNNACLIFFE, A. and PONDER, B.A.J., Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. mol. Genet., 3, 237-241 (1994).
10. FERRER, J.P., HALPERIN, I., CONGET, J.I., ALSINA, M., MARTINEZ-OSABA, M.J., PALOU, J., BOMBI, J.A. and VILARDELL, E., Primary localized cutaneous amyloidosis and familial medullary thyroid carcinoma. Clin. Endocrinol., 34, 435-439 (1991).
11. FRANC, B. and 12 OTHERS, Immunohistochemistry in medullary thyroid carcinoma: prognosis and distinction between hereditary and sporadic tumors. Henry Ford Hosp. Med. J., 35, 139-142 (1987).
12. HOFSTRA, R.M.W., LANDSVATER, R.M., CECCHERINI, I., STULP, R.P., STELWAGEN, T., LUO, Y., PASINI, B., HÖPPENER, J.W.M., PLOOS VAN AMSTEL, H.K., ROMEO, G., LIPS, C.J.M. and BUYS, C.H.C.M., A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature (Land), 367, 375-376 (1994).
13. KOMMINOTH, P., KUNZ, E.K., MATIAS-GUIU, X., HlORT, O., CHRIS- TIANSEN, G., COLOMER, A., ROTH, J. and HEITZ, P.U., Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer, 76,479-489 (1995).
14. LANDSVATER, R.M., JANSEN, R.P.M., HOFSTRA, R.M.W., BUYS, C.H.C.M., LIPS, C.J.M. and VAN AMSTEL, H.K.P., Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. Hum Genet., 97, 11-14 (1996).
15. LIPS, C.J., LEO, J.R., BERENDS, M.J., MINDER, W.H., BLOK, A.P., GEERDINK, R.A., HACKENG, W.H., ROELOFS, J.M., VASEN, H.F. and VETTE, J.K., Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery. Henry Ford Hosp. med. J., 35, 133-138 (1987).
16. LIPS, C.J.M. and 15 OTHERS, Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. New Engl. J. Med., 331, 828-835 (1994).
17. MARUYAMA, S., IWASHITA, T., IMAI, T., FUNAHASHI, H., CECCHERINI, I., LUO, Y., ROMEO, G., MATSUO, S., MATSUYAMA, M. and TAKAHASHI, M., Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B. Jap. J. Cancer Res., 85, 879-882 (1994).
18. MULLIGAN, L.M. and 13 OTHERS, Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (Land.), 363, 458-460 (1993).
19. MULLIGAN, L.M. and 12 OTHERS, Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet., 6, 70-74 (1994a).
20. MULLIGAN, L.M., ENG, C., HEALEY, C.S., PONDER, M.A., FELDMAN, G.L., LI, P., JACKSON, C.E. and PONDER, B.A.J., A de novo mutation of the RET proto-oncogene in a patient with MEN 2A. Hum. mol. Genet., 3, 1007-1008 (1994b).
21. MULLIGAN, L.M. and 26 OTHERS, Genotype-phenotype correlation in MEN2: report of the international RET mutation consortium. J. intern. Med., (1995). 238:343-6 (1995).
22. SCHUFFENECKER, I., BILLAUD, M., CALENDER, A., CHAMBE, B., GINET, N., CALMETTES, C., MODIGLIANI, E. and LENOIR, G.M., RET protooncogene mutations in French MEN 2A and FMTC families. Hum. mol. Genet., 3, 1939-1943 (1994).
23. ZEDENIUS, J., WALLIN, G., HAMBERGER, B., NORDENSKJÖLD, M., WEBER, G. and LARSSON, C., Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTCs. Hum. mol. Genet., 3, 1259-1262 (1994).